Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
Recap by typeshit. Full story at AD HOC NEWS.
She talks with Annika Urban about combining GLP-1 treatment with behavioral coaching and telehealth care.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
MUSC Health suggests the familiar ABCs of heart health may change, with GLP-1 medications now part of cardiovascular prevention for some patients.
Bauer, who has a PhD in neuroscience and endocrinology, joins Geller to discuss insulin resistance and the shame many women feel about their weight.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Superpower says the drug carries radiation straight to cancer cells and cites a phase 3 trial showing a 79% lower risk of progression or death. A 14-part thread.
Loading…